# Revolution Medicines, Inc.: Form 8-K, filed Sep 1, 2026

- Company: [Revolution Medicines, Inc.](/companies/rvmd.md) (CIK 1628171)
- Form: 8-K
- Filed: 2026-09-01
- Accepted by EDGAR: Sep 1, 2026, 06:00 ET
- Period: 2026-08-27
- Accession: 0001193125-26-377362
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1628171/000119312526377362/rvmd-20260827.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1628171/000119312526377362/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1628171/000119312526377362/rvmd-20260827.htm

Filed Sep 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-377362. Last ingested by Listed: Nov 12, 2026, 18:06 ET. No prices; not investment advice.